103.21 USD
↗ 1.04 (1.02%)AT CLOSE (11:59 AM EDT)
Icon Plc
ICLRNASDAQ • USD
103.20
↘ 0.01 (0.01%)
POST MARKET (AS OF 05:27 PM EDT)
Post Market
AS OF 05:27 PM EDT
103.20
↘ 0.01 (0.01%)
Market: CLOSED
Open?$102.42
High?$103.34
Low?$99.37
Prev. Close?$102.17
Volume?3.4M
Avg. Volume?1.1M
VWAP?$101.40
Rel. Volume?3.10x
Bid / Ask
Bid?$94.01 × 100
Ask?$110.00 × 200
Spread?$15.99
Midpoint?$102.01
Valuation & Ratios
Market Cap?7.9B
Shares Out?80.8M
Float?80.3M
Float %?99.5%
P/E Ratio?23.33
P/B Ratio?4.07
EPS?$4.42
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.01Strong
Quick Ratio?2.01Strong
Cash Ratio?0.87Adequate
Debt/Equity?0.18Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?23.3FAIR▾
P/B?4.07FAIR▾
P/S?2.68CHEAP▾
P/FCF?15.8CHEAP▾
EV/EBITDA?15.5FAIR▾
EV/Sales?2.48CHEAP▾
Returns & Efficiency
ROE?17.5%STRONG▾
ROA?9.7%STRONG▾
Cash Flow & Enterprise
FCF?$498.9M
Enterprise Value?$7.3B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.